A supplementary infusion of glucose-dependent insulinotropic polypeptide (GIP) with a meal does not significantly improve the β cell response or glucose tolerance in type 2 diabetes mellitus
- 1 January 1989
- journal article
- research article
- Published by Elsevier in Diabetes Research and Clinical Practice
- Vol. 7 (4) , 263-269
- https://doi.org/10.1016/0168-8227(89)90014-4
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- The effects of glucose-dependent insulinotropic polypeptide infused at physiological concentrations in normal subjects and Type 2 (non-insulin-dependent) diabetic patients on glucose tolerance and B-cell secretionDiabetologia, 1987
- Incretin Effects of Increasing Glucose Loads in Man Calculated from Venous Insulin and C-Peptide Responses*Journal of Clinical Endocrinology & Metabolism, 1986
- Insulin and C-peptide levels after oral and intravenous glucose. Contribution of enteroinsular axis to insulin secretionDiabetes, 1986
- Reduced incretin effect in Type 2 (non-insulin-dependent) diabetesDiabetologia, 1986
- The effect of glucose-dependent insulinotropic polypeptide infused at physiological concentrations on the release of insulin in manDiabetologia, 1982
- Insulin secretion in diabetes mellitusThe American Journal of Medicine, 1981
- Release of immunoreactive gastric inhibitory polypeptide (IR-GIP) by oral ingestion of food substancesThe American Journal of Surgery, 1975
- Gastric Inhibitory Polypeptide (GIP) Stimulated by Fat Ingestion in ManJournal of Clinical Endocrinology & Metabolism, 1975
- STIMULATION OF INSULIN SECRETION BY GASTRIC INHIBITORY POLYPEPTIDE IN MAN.1Journal of Clinical Endocrinology & Metabolism, 1973
- Insulin Secretion in Response to Glycemic Stimulus: Relation of Delayed Initial Release to Carbohydrate intolerance in Mild Diabetes Mellitus*Journal of Clinical Investigation, 1967